Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
04 avr. 2024 07h05 HE
|
Celcuity Inc.
MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that...
IMN celebrates 30th Anniversary as the Premier Real Estate Conference Organizer
27 mars 2024 09h00 HE
|
IMN
Hosting over 50 events annually, IMN provides a high-quality intelligence and networking platform that drives industry connections, deal flow and knowledge
HR Community Readies for Next Month’s EPIC Conference in Las Vegas
27 mars 2024 07h00 HE
|
EPIC
HR Community Readies for Next Month’s EPIC Conference in Las Vegas
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
22 mars 2024 12h30 HE
|
Marker Therapeutics
HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...
HR Technology Conference & Exposition® Europe Announces Additional Agenda Details
18 mars 2024 06h00 HE
|
HR Technology Conference & Exposition (R)
HR Technology Conference & Exposition® Europe to Offer Unfettered Access to Industry’s Leading Thinkers
The Devon Group Expands Partner Program, Teams Up with Sara in the City Events
28 févr. 2024 07h00 HE
|
The Devon Group
The Devon Group Expands Partner Program, Teams Up with Sara in the City Events
Mendus medverkar på flera branschkonferenser
27 févr. 2024 02h00 HE
|
Mendus AB
Pressmeddelande Stockholm den 27 februari 2024 Mendus AB (“Mendus” publ; IMMU. ST), ett biofarmabolag med fokus på immunterapier riktade mot tumöråterfall, meddelade idag att bolaget kommer att...
Mendus to participate in upcoming industry conferences
27 févr. 2024 02h00 HE
|
Mendus AB
Press release Stockholm, Sweden, February 27, 2024 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it...
Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
26 févr. 2024 08h30 HE
|
Ocugen
MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
MC2 Therapeutics to Present at Upcoming Conferences
26 févr. 2024 07h00 HE
|
MC2 Therapeutics
MC2 Therapeutics to Present at Upcoming Conferences Copenhagen, February 26th, 2024 – MC2 Therapeutics, a commercial stage biotech company focused on developing novel treatment paradigms within...